Harrow Health to Participate in B. Riley Securities’ Annual Neuro & Ophthalmology Investor Conference

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic‑focused healthcare company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the B. Riley Securities’ Annual Neuro & Ophthalmology Investor Conference, which will be held virtually on Wednesday, April 27, 2022, at 2:00 p.m. ET/1:00 p.m. CT. A live webcast of the presentation will be available on the Company’s website, www.harrowinc.com